Clinical Significance of Axin and β-catenin Protein Expression in Primary Hepatocellular Carcinomas |
Guan, Cheng-Nong
(Department of Oncology, the Affiliated Hospital of Guangdong Medical College)
Chen, Xin-Ming (Department of Oncology, the Affiliated Hospital of Guangdong Medical College) Lou, Hai-Qing (Department of Oncology, the Affiliated Hospital of Guangdong Medical College) Liao, Xiang-Hui (Department of Oncology, the Affiliated Hospital of Guangdong Medical College) Chen, Bao-Ying (Department of Oncology, the Affiliated Hospital of Guangdong Medical College) Zhang, Pei-Weng (Department of Oncology, the Affiliated Hospital of Guangdong Medical College) |
1 | Ashibara K, Saito T, Mizumoto H, et al (2002). Mutation of beta-catenin gene in endometrialcancer but not in associated hyperplasis. Med Electron Microsc, 35, 9-15. DOI |
2 | Daa T, Kashima K, Kaku N, et al (2004). Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Mod Pathol, 17, 1475-82. DOI |
3 | Hasegawa T, Yokoyama R, Matsuno Y, et al (2001). Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol, 32, 257-63. DOI ScienceOn |
4 | Hino S, Michiue T, Asashima M, et al (2003). Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin. J Biol Chem, 278, 14066-73. DOI |
5 | Jin L H, Shao QJ, Luo W, et al (2003). Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer, 107, 696-9. DOI |
6 | Karim R, Tse G, Putti T, et al (2004). The significance of the Wnt pathway in the patho-logy of human cancers. Pathology, 369, 120-8. |
7 | Kikuchi A (1999). Roles of Axin in the Wnt signalling pathway. Cell Signal, 11, 777-88. DOI |
8 | Liu C, Li Y, Semenov M, et al (2002). Control of beta-catenin phosphorylation/degradation by a Dual-kinase mechanism. Cell, 108, 837-47. DOI |
9 | Luo W, Lin SC (2004). Axin: a master scaffold for multiple signaling pathways. Neurosignals, 13, 99-113. DOI ScienceOn |
10 | Nakajima M, Fukuchi M, Miyazaki T, et al (2003). Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer, 88, 1734-9. DOI |
11 | Neo SY, Zhang Y, Yaw LP, et al (2000). Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate beta-catenin leveks. Biochem Biophys Res Commun, 272, 144-50. DOI |
12 | Pirinen RT, Hirvikoski P, Johansson RT, et al (2001). Reduced expression Of -catenin, -catenin, and -catenin is associated with high cell proliferative activity and poor differentiation in nonsmall cell lung cancer. J Clin Pathol, 54, 391-5. DOI ScienceOn |
13 | Rubinfeld B, Robbins P, EL-Gamil M, et al (1997). Stailization of -catenin by genetic defects in melanoma cell line. Science, 275, 1790-2. DOI ScienceOn |
14 | Rui Y, Xu Z, Lin S, et al (2004). Axin stimulates p53 functions by activation of HIPK2 kinase through Multimeric complex formation. EMBO J, 23, 4583-94. DOI |
15 | Satoh S, Daigo Y, Furukawa Y, et al (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 24, 245-50. DOI ScienceOn |
16 | Takahashi M, Tsunoda T, Seiki M, et al (2002). Identification Of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene, 21, 5861-7. DOI |
17 | Ueta T, Ikeguchi M, Hirooka Y, et al (2002). Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep, 9, 1197-203. |
18 | Zeng L, Fagotto F, Zhang T, et al (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axin formation. Cell, 90, 181-92. DOI |
19 | Zeng L, Fagotto F, Zhang T, et al (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell, 90, 181-92. DOI |